BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15674337)

  • 21. Mitochondrial activity is involved in the regulation of myoblast differentiation through myogenin expression and activity of myogenic factors.
    Rochard P; Rodier A; Casas F; Cassar-Malek I; Marchal-Victorion S; Daury L; Wrutniak C; Cabello G
    J Biol Chem; 2000 Jan; 275(4):2733-44. PubMed ID: 10644737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
    De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
    Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD; Reagan SR; Mahadevan MS
    J Cell Biol; 2002 Nov; 159(3):419-29. PubMed ID: 12427866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation.
    Jane DT; Morvay LC; Koblinski J; Yan S; Saad FA; Sloane BF; Dufresne MJ
    Biol Chem; 2002 Dec; 383(12):1833-44. PubMed ID: 12553720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of c-erbA proto-oncogene enhances myogenic differentiation.
    Carnac G; Albagli-Curiel O; Desclozeaux M; Vandromme M; Glineur C; Bègue A; Laudet V; Bonnieu A
    Oncogene; 1993 Nov; 8(11):3103-10. PubMed ID: 8414512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial activity regulates myoblast differentiation by control of c-Myc expression.
    Seyer P; Grandemange S; Busson M; Carazo A; Gamaléri F; Pessemesse L; Casas F; Cabello G; Wrutniak-Cabello C
    J Cell Physiol; 2006 Apr; 207(1):75-86. PubMed ID: 16261590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of myogenin expression in normal and transformed myogenic cell lines.
    Arnold HH; Braun T; Bober E; Buchberger A; Winter B; Salminen A
    Symp Soc Exp Biol; 1992; 46():37-51. PubMed ID: 1341049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
    Tubaro C; Arcuri C; Giambanco I; Donato R
    J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetyl-CoA carboxylase beta expression mediated by MyoD and muscle regulatory factor 4 is differentially affected by retinoic acid receptor and retinoid X receptor.
    Kim JY; Lee JJ; Kim KS
    Exp Mol Med; 2003 Feb; 35(1):23-9. PubMed ID: 12642900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
    Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
    Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a novel thyroid hormone receptor alpha variant involved in the regulation of myoblast differentiation.
    Casas F; Busson M; Grandemange S; Seyer P; Carazo A; Pessemesse L; Wrutniak-Cabello C; Cabello G
    Mol Endocrinol; 2006 Apr; 20(4):749-63. PubMed ID: 16322094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of the cell-specific activity of v-erb A in quail myoblasts.
    Cassar-Malek I; Marchal S; Rochard P; Wrutniak C; Samarut J; Cabello G
    Oncogene; 1997 Mar; 14(9):1099-108. PubMed ID: 9070659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of JAK3 in myogenic differentiation.
    Jang YN; Lee IJ; Park MC; Baik EJ
    Cell Signal; 2012 Mar; 24(3):742-9. PubMed ID: 22120524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expression of myogenin.
    Naka A; Iida KT; Nakagawa Y; Iwasaki H; Takeuchi Y; Satoh A; Matsuzaka T; Ishii KA; Kobayashi K; Yatoh S; Shimada M; Yahagi N; Suzuki H; Sone H; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2013 Jan; 430(2):664-9. PubMed ID: 23211595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational transitions in BTG1 antiproliferative protein and their modulation by disease mutants.
    Kots E; Mlynarczyk C; Melnick A; Khelashvili G
    Biophys J; 2022 Oct; 121(19):3753-3764. PubMed ID: 35459639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1.
    Liu C; Tao T; Xu B; Lu K; Zhang L; Jiang L; Chen S; Liu D; Zhang X; Cao N; Chen M
    Oncol Lett; 2015 Aug; 10(2):619-624. PubMed ID: 26622543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. v-erb A and v-erb B do not cooperate in quail myoblasts.
    Cassarmalek I; Marchal S; Rochard P; Wrutniak C; Samarut J; Cabello G
    Int J Oncol; 1997 Nov; 11(5):1095-101. PubMed ID: 21528308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.